Note to our followers: Due to a lack of sufficient funding, HealthNewsReview.org will cease daily publication of new content at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. If you wish to donate, your gift might help keep the site available to the public for a few more years, by defraying costs of web hosting and maintenance. All of our 6,000+ published articles contain lessons to help people improve their critical thinking about health care. Read more about our change in status. And here's how to make a donation.

Use of “cure” overwhelms any caveats coming later in WaPost Ebola story

Zoloft as Ebola cure? – blared the Washington Post headline.

Zoloft as Ebola cure?

 

“What if the cure for Ebola were already in your local pharmacy?” asked the question-mark journalism first line of the story.

Mouse 410x273This was about a mouse study.

And when you add, deep in the story, “A lot of drugs that look miraculous in mice end up doing nothing in humans,” it is too little too late.

Appreciation of that fact should have entered into the deliberation over what the headline should be, and what the first line of the story should be.

This is about Ebola, not toenail fungus. We should proceed slowly before tossing around the “cure” word in this context.

You might also like

Comments

We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.

We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.

Comments are closed.